Meet the Genezen Team
We are here to help you take your viral vector where it needs to go.
Meet the team
Specialist expertise in the gene and cell therapy space
Our team boasts a wealth of experience, from academia to long-established CDMO experts. Our team is on hand to support you throughout your journey to therapy, we understand your needs and are driven to help you bring your products to patients. Learn more about our experience, what brings us to Genezen and what motivates us every day.
Management
Board of Directors
Scientific Advisory Board
See how we got here
Evolution
Founded in 2014 by current Chairman Bill Vincent, our history is packed with innovation and ambition. Following investment by Ampersand Capital Partners’ in 2021, Genezen is catapulted forward built on a foundation of expansive knowledge in lentiviral and retroviral vector.
Our mission & vision
We collaborate with our clients to connect good science with better cures. With superior service and technical expertise, we develop and manufacture cell and gene therapy products of the highest quality.
See our vacancies
Join the team
We want our employees to be innovative, collaborative problem solvers who are dedicated to meeting the challenges of our clients and a fast-growing market.